Celanese Corporation
CEChemicals
$48.32−1.08%As of Oct 29vs prior close
- Market cap
- $5.3B
- P/E (TTM)
- –
- P/E (FY1)
- 8.1×
- From 52W high
- −30.17%
- EPS (LTM)
- -$10.69
- Revenue (LTM)
- $9.7B
- Net margin
- -12.04%
- Dividend yield
- 0.25%
Nomior Score
37
Patient ValueSpeculativeBottom 24% of the scored universe
Growth29
Quality22
Value72
Momentum58
Resilience35
Growth
+6.56%revenue a year over 9 fiscal years
YE16 $5.4BLTM $9.7B
Connections
Revenue to profitQ2 YE26
5% of revenue became net profit, down 3 pts on a year.
Who owns it
1fund, 1 tracked portfolio